Supplementation of maternal diets during pregnancy and for 6 months postpartum and infant diets thereafter with small-quantity lipid-based nutrient supplements does not promote child growth by 18 months of age in rural malawi: A randomized controlled trial
dc.contributor.author | Ashorn, P. | |
dc.contributor.author | Alho, L. | |
dc.contributor.author | Ashorn, U. | |
dc.contributor.author | Cheung, Y.B. | |
dc.contributor.author | Dewey, K.G. | |
dc.contributor.author | Gondwe, A. | |
dc.contributor.author | Harjunmaa, U. | |
dc.contributor.author | Lartey, A. | |
dc.contributor.author | Phiri, N. | |
dc.contributor.author | Phiri, T.E. | |
dc.contributor.author | Vosti, S.A. | |
dc.contributor.author | Zeilani, M. | |
dc.contributor.author | Maleta, K. | |
dc.date.accessioned | 2018-11-14T13:29:28Z | |
dc.date.available | 2018-11-14T13:29:28Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Background: Intrauterine growth restriction may be reduced by supplementing maternal diets during pregnancy, but few studies have assessed the impact of combined prenatal and postnatal interventions on child growth. Objective: We tested a hypothesis that provision of small-quantity lipid-based nutrient supplements (SQ-LNSs) to mothers in pregnancy and 6 mo postpartum and to their infants from 6 to 18 mo of age would promote infant and child growth in the study area in rural Malawi. Methods: We enrolled 869 pregnant women in a randomized trial in Malawi. During pregnancy and 6 mo thereafter, the women received daily 1 capsule of iron-folic acid (IFA), 1 capsule containing 18 micronutrients (MMN), or one 20-g sachet of SQ-LNS [lipid-based nutrient supplements (LNS), containing 21 MMN, protein, carbohydrates, essential fatty acids, and 118 kcal]. Children in the IFA andMMN groups received no supplementation; children in the LNS group received SQ-LNSs from 6 to 18 mo. Primary outcome was child length at 18 mo. Results: At 18 mo, the mean length in the IFA,MMN, and LNS groups was 77.0, 76.9, and 76.8 cm (P = 0.90), respectively, and the prevalence of stuntingwas 32.7%, 35.6%, and 37.9%(P = 0.54), respectively. No intergroup differenceswere found in the mean weight, head circumference, or midupper arm circumference or the proportions with low z scores for these variables (P > 0.05). Covariate adjustment did not change the analysis results, and the associations between the intervention and child length were not modified by maternal parity, age, or nutritional status (P > 0.10). Conclusions: The findings do not support a hypothesis that provision of SQ-LNSs to women in pregnancy and postpartum and to children from 6 to 18 mo of age would promote child growth in this Malawian study area. This trial was registered at clinicaltrials.gov as NCT01239693. © 2015 American Society for Nutrition. | en_US |
dc.identifier.other | 10.3945/jn.114.207225 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/25518 | |
dc.language.iso | en | en_US |
dc.publisher | Journal of Nutrition | en_US |
dc.subject | Dietary supplementation | en_US |
dc.subject | Infant | en_US |
dc.subject | Linear growth failure | en_US |
dc.subject | LNS | en_US |
dc.subject | Postnatal intervention | en_US |
dc.subject | Prenatal intervention | en_US |
dc.subject | Stunting | en_US |
dc.subject | Sub-saharan Africa | en_US |
dc.title | Supplementation of maternal diets during pregnancy and for 6 months postpartum and infant diets thereafter with small-quantity lipid-based nutrient supplements does not promote child growth by 18 months of age in rural malawi: A randomized controlled trial | en_US |
dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: